Publications
Detailed Information
Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors
Cited 29 time in
Web of Science
Cited 32 time in Scopus
- Authors
- Issue Date
- 2020-07
- Publisher
- University of Chicago Press
- Citation
- Clinical Infectious Diseases, Vol.71 No.2, pp.422-425
- Abstract
- Among prospectively enrolled adult patients with cancer receiving immune checkpoint inhibitors (ICIs; n = 46) or cytotoxic agents (n = 90), seroprotection and seroconversion rates after seasonal quadrivalent influenza vaccinations were higher with ICI than with cytotoxic chemotherapy. These results support annual influenza vaccinations for cancer patients receiving ICIs.
- ISSN
- 1058-4838
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.